From the Characterization of the Cholesterol-epoxide Pathway Deregulation to New Therapeutic Perspectives in Breast Cancers
Clinical trial NCT02863900 · UNKNOWN
Trial details
- NCT number
- NCT02863900
- Sponsor
- Institut Claudius Regaud
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-12-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.